These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19202515)

  • 1. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
    Novo G; Assennato P; Caruso M; Turturici C; Balistreri CR; Amoroso GR; Fazio G; Rotolo A; Coppola G; Hoffmann E; Caruso C; Novo S
    Minerva Cardioangiol; 2009 Feb; 57(1):7-11. PubMed ID: 19202515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease.
    Ikonomidis I; Lekakis J; Revela I; Andreotti F; Nihoyannopoulos P
    Eur Heart J; 2005 Aug; 26(16):1618-24. PubMed ID: 15800017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of the markers of inflammation in acute coronary syndromes].
    Ben Khalfallah A; Sanaa I; Annabi N; Ousji M; Aloui H; Naffeti S
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):899-905. PubMed ID: 16231577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.
    Oltrona L; Ottani F; Galvani M;
    Am Heart J; 2004 Sep; 148(3):405-15. PubMed ID: 15389226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
    Passoni F; Morelli B; Seveso G; Lazzati L; Beria G; Del Rosso G; D'Urbano M; Cafiero F; Mariani G; De Servi S
    Ital Heart J; 2002 Jan; 3(1):28-33. PubMed ID: 11899586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with non-ST-elevation myocardial infarction and without chest pain are treated less aggressively and experience higher in-hospital mortality.
    Zdzienicka J; Siudak Z; Zawiślak B; Dziewierz A; Rakowski T; Dubiel J; Dudek D
    Kardiol Pol; 2007 Jul; 65(7):769-75; discussion 776-7. PubMed ID: 17694458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.
    Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Bertomeu V; Pellicer M; Chorro FJ
    Int J Cardiol; 2005 Feb; 98(2):277-83. PubMed ID: 15686779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum sCD40L detection for risk evaluation of acute coronary syndromes].
    Xu BL; Bei CH; Wang R; Lei XX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1656-7. PubMed ID: 17121725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
    Dziewierz A; Siudak Z; Dykla D; Rakowski T; Mielecki W; Dubiel JS; Dudek D
    Kardiol Pol; 2009 Feb; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
    J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
    Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
    Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of C-reactive protein and troponin T level in patients with unstable angina pectoris].
    Tanaka H; Tsurumi Y; Kasanuki H
    J Cardiol; 2006 Apr; 47(4):173-9. PubMed ID: 16637251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.